Completed
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors - CA047-004
Aggiornato:
2 dicembre, 2025
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice